Federal Supply Schedule 36F79722D0160

Award Date 8/1/22
Last Date to Order 7/31/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at a ceiling of $250,000.00, was awarded to TWI Pharmaceuticals USA, Inc. on February 1, 2023 with a period of performance through January 31, 2028. The contract is for FSS 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS," indicating that the scope includes the...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract has a ceiling value of $419,690.00 and a period of performance ending on September 1, 2027. The prime contractor is Altathera Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The purpose of this FSS contract is to provide the VA VISN 12 with "Drugs,...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, identified as 36F79721D0186, is for the provision of drugs, pharmaceuticals, and hematology-related products under FSS contract 65 I B. The contract has a total ceiling value of $2,225,000.00 and a period of performance extending until June 14, 2026. As a Federal Supply Schedule contract,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV represents a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Amerisource Health Services, LLC. The contract, valued at up to $750,000.00, is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSC 65 I B) for the Veterans Integrated Service Network 12 region. The contract is a multiple-award FSS with a period of performance running from September 15, 2023 to September 14, 2028. As an FSS contract,...
The federal contract IDV award is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at a ceiling of $500,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The prime contractor for this multiple-award contract is Usantibiotics LLC, a for-profit organization located in Alpharetta, Georgia. The contract has a period of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV is a Federal Supply Schedule (FSS) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Cameron Pharmaceuticals, LLC. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $368,460.00 and a period of performance from June 1, 2024 to May 31, 2029. The contract is a multiple award FSS with no set-aside. As an FSS contract, it...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The prime contractor is Usantibiotics LLC, a for-profit organization. The contract is an interim agreement with a ceiling value of $25,000.00 and a period of performance through April 1, 2023. The contract does...
The key details regarding the federal contract IDV award are as follows: The contract is a Federal Supply Schedule (FSS) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency. The contract has a period of performance from February 1, 2024 to January 31, 2029, with a ceiling value of $225,000.00. The contract was awarded to Proficient RX LP, a for-profit limited liability company and manufacturer of goods. The contract falls under FSS Code 65 I B, covering...

This federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The $435,680 contract was awarded on August 1, 2022 to Sarfez Pharmaceuticals, Inc., a minority-owned small disadvantaged business, and has a period of performance through July 31, 2027.

The contract provides for the delivery of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B product category. While no set-asides were used, the prime contractor Sarfez Pharmaceuticals is a certified small disadvantaged business. The contract aims to procure a wide range of pharmaceutical and medical supplies to support the healthcare needs of U.S. military veterans served by VISN 12 facilities across multiple states.

Generated 1/26/25, 12:01 AM